Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.

<h4>Background</h4>Fecal microbiota transplantation (FMT) has been recognized as a novel treatment for ulcerative colitis (UC). However, its efficacy and safety remain unclear.<h4>Objective</h4>We conducted this systematic review to assess the efficacy and safety of FMT in UC...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanqiang Shi, Yiwei Dong, Wenhui Huang, Decong Zhu, Hua Mao, Peizhu Su
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0157259
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849431648082329600
author Yanqiang Shi
Yiwei Dong
Wenhui Huang
Decong Zhu
Hua Mao
Peizhu Su
author_facet Yanqiang Shi
Yiwei Dong
Wenhui Huang
Decong Zhu
Hua Mao
Peizhu Su
author_sort Yanqiang Shi
collection DOAJ
description <h4>Background</h4>Fecal microbiota transplantation (FMT) has been recognized as a novel treatment for ulcerative colitis (UC). However, its efficacy and safety remain unclear.<h4>Objective</h4>We conducted this systematic review to assess the efficacy and safety of FMT in UC.<h4>Data sources</h4>PubMed, EMBASE, Cochrane Central, Web of Science Core Collection, and three other Chinese databases were searched for reports of FMT in UC with clear outcomes.<h4>Data extraction and synthesis</h4>We estimated pooled rates [with 95% confidence interval (CI)] of clinical remission among 15 cohort studies and clinical response among 16 cohort studies.<h4>Results</h4>Twenty five studies (2 randomized controlled trials, 15 cohort studies, and 8 case studies) with 234 UC patients were included. Overall, 41.58% (84/202) patients achieved clinical remission (CR) and 65.28% (126/193) achieved clinical response. Among the cohort studies, the pooled estimate of patients who achieved CR and clinical response were 40.5% (95% CI 24.7%-58.7%), and 66.1% (95% CI 43.7%-83.0%). Most adverse events were slight and self-resolving. The analyses of gut microbiota in 7 studies showed that FMT could increase microbiota diversity and richness, similarity, and certain change of bacterial composition.<h4>Conclusion</h4>FMT provides a promising effect for UC with few adverse events. Successful FMT may be associated with an increase in microbiota diversity and richness, similarity, and certain change of bacterial composition.
format Article
id doaj-art-79d5a13871c6471db609a5eef90d277d
institution Kabale University
issn 1932-6203
language English
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-79d5a13871c6471db609a5eef90d277d2025-08-20T03:27:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015725910.1371/journal.pone.0157259Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.Yanqiang ShiYiwei DongWenhui HuangDecong ZhuHua MaoPeizhu Su<h4>Background</h4>Fecal microbiota transplantation (FMT) has been recognized as a novel treatment for ulcerative colitis (UC). However, its efficacy and safety remain unclear.<h4>Objective</h4>We conducted this systematic review to assess the efficacy and safety of FMT in UC.<h4>Data sources</h4>PubMed, EMBASE, Cochrane Central, Web of Science Core Collection, and three other Chinese databases were searched for reports of FMT in UC with clear outcomes.<h4>Data extraction and synthesis</h4>We estimated pooled rates [with 95% confidence interval (CI)] of clinical remission among 15 cohort studies and clinical response among 16 cohort studies.<h4>Results</h4>Twenty five studies (2 randomized controlled trials, 15 cohort studies, and 8 case studies) with 234 UC patients were included. Overall, 41.58% (84/202) patients achieved clinical remission (CR) and 65.28% (126/193) achieved clinical response. Among the cohort studies, the pooled estimate of patients who achieved CR and clinical response were 40.5% (95% CI 24.7%-58.7%), and 66.1% (95% CI 43.7%-83.0%). Most adverse events were slight and self-resolving. The analyses of gut microbiota in 7 studies showed that FMT could increase microbiota diversity and richness, similarity, and certain change of bacterial composition.<h4>Conclusion</h4>FMT provides a promising effect for UC with few adverse events. Successful FMT may be associated with an increase in microbiota diversity and richness, similarity, and certain change of bacterial composition.https://doi.org/10.1371/journal.pone.0157259
spellingShingle Yanqiang Shi
Yiwei Dong
Wenhui Huang
Decong Zhu
Hua Mao
Peizhu Su
Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
PLoS ONE
title Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
title_full Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
title_fullStr Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
title_full_unstemmed Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
title_short Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
title_sort fecal microbiota transplantation for ulcerative colitis a systematic review and meta analysis
url https://doi.org/10.1371/journal.pone.0157259
work_keys_str_mv AT yanqiangshi fecalmicrobiotatransplantationforulcerativecolitisasystematicreviewandmetaanalysis
AT yiweidong fecalmicrobiotatransplantationforulcerativecolitisasystematicreviewandmetaanalysis
AT wenhuihuang fecalmicrobiotatransplantationforulcerativecolitisasystematicreviewandmetaanalysis
AT decongzhu fecalmicrobiotatransplantationforulcerativecolitisasystematicreviewandmetaanalysis
AT huamao fecalmicrobiotatransplantationforulcerativecolitisasystematicreviewandmetaanalysis
AT peizhusu fecalmicrobiotatransplantationforulcerativecolitisasystematicreviewandmetaanalysis